Versa Vascular Secures $27.3M Oversubscribed Series C Funding and Appoints David Hovda as CEO to Advance Novel Tricuspid Valve Repair Technology Versa Vascular Dec 8 Written By Christine Johnson Christine Johnson
Versa Vascular Secures $27.3M Oversubscribed Series C Funding and Appoints David Hovda as CEO to Advance Novel Tricuspid Valve Repair Technology Versa Vascular Dec 8 Written By Christine Johnson Christine Johnson
